Neoadjuvant Letrozole Plus Metformin vs Letrozole Plus Placebo for ER-positive Postmenopausal Breast Cancer

NCT01589367 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

208

Enrollment

OTHER

Sponsor class

Conditions

Hormone Receptor Positive Malignant Neoplasm of Breast

Interventions

DRUG: Metformin
DRUG: Placebo

Sponsor

Seoul National University Hospital